SEC24A
Basic information
Region (hg38): 5:134648785-134727909
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SEC24A gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 43 | 43 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 43 | 0 | 0 |
Variants in SEC24A
This is a list of pathogenic ClinVar variants found in the SEC24A region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
5-134649171-A-G | not specified | Uncertain significance (Jun 11, 2021) | ||
5-134661216-G-T | not specified | Uncertain significance (Jan 24, 2024) | ||
5-134661224-A-G | not specified | Uncertain significance (Sep 16, 2021) | ||
5-134661277-C-G | not specified | Uncertain significance (Oct 05, 2023) | ||
5-134661299-C-G | not specified | Uncertain significance (Aug 14, 2023) | ||
5-134661343-A-G | not specified | Uncertain significance (Nov 20, 2023) | ||
5-134661373-A-C | not specified | Uncertain significance (Aug 09, 2021) | ||
5-134661422-C-A | not specified | Uncertain significance (Sep 06, 2022) | ||
5-134661437-A-C | not specified | Uncertain significance (May 26, 2022) | ||
5-134661491-C-A | not specified | Uncertain significance (Jan 20, 2023) | ||
5-134661524-C-A | not specified | Uncertain significance (May 16, 2022) | ||
5-134666874-C-T | not specified | Uncertain significance (Feb 28, 2024) | ||
5-134666879-G-C | not specified | Uncertain significance (Dec 12, 2023) | ||
5-134666901-C-T | not specified | Uncertain significance (Oct 05, 2021) | ||
5-134666915-C-T | not specified | Uncertain significance (Aug 30, 2022) | ||
5-134666955-A-T | not specified | Uncertain significance (May 23, 2024) | ||
5-134671820-A-G | not specified | Uncertain significance (May 04, 2022) | ||
5-134671859-G-A | not specified | Uncertain significance (Jun 21, 2022) | ||
5-134674651-G-A | not specified | Uncertain significance (Nov 15, 2021) | ||
5-134674704-A-C | not specified | Uncertain significance (Apr 09, 2024) | ||
5-134675143-G-A | not specified | Uncertain significance (Oct 29, 2021) | ||
5-134675148-C-T | not specified | Uncertain significance (Nov 03, 2023) | ||
5-134676037-C-T | not specified | Uncertain significance (Dec 12, 2023) | ||
5-134676082-A-C | not specified | Uncertain significance (Aug 17, 2021) | ||
5-134679671-G-A | not specified | Uncertain significance (Jun 11, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SEC24A | protein_coding | protein_coding | ENST00000398844 | 23 | 79035 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
8.77e-9 | 1.00 | 124743 | 0 | 54 | 124797 | 0.000216 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.406 | 551 | 578 | 0.953 | 0.0000288 | 7047 |
Missense in Polyphen | 118 | 141.85 | 0.83185 | 1666 | ||
Synonymous | -0.557 | 222 | 212 | 1.05 | 0.0000108 | 2230 |
Loss of Function | 4.12 | 24 | 57.8 | 0.415 | 0.00000302 | 688 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000350 | 0.000350 |
Ashkenazi Jewish | 0.000299 | 0.000298 |
East Asian | 0.000278 | 0.000278 |
Finnish | 0.000139 | 0.000139 |
European (Non-Finnish) | 0.000241 | 0.000230 |
Middle Eastern | 0.000278 | 0.000278 |
South Asian | 0.000320 | 0.000294 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Component of the coat protein complex II (COPII) which promotes the formation of transport vesicles from the endoplasmic reticulum (ER). The coat has two main functions, the physical deformation of the endoplasmic reticulum membrane into vesicles and the selection of cargo molecules for their transport to the Golgi complex (PubMed:20427317, PubMed:17499046, PubMed:18843296). Plays a central role in cargo selection within the COPII complex and together with SEC24B may have a different specificity compared to SEC24C and SEC24D. May package preferentially cargos with cytoplasmic DxE or LxxLE motifs and may also recognize conformational epitopes (PubMed:17499046, PubMed:18843296). {ECO:0000269|PubMed:17499046, ECO:0000269|PubMed:18843296, ECO:0000269|PubMed:20427317}.;
- Pathway
- Protein processing in endoplasmic reticulum - Homo sapiens (human);Sterol Regulatory Element-Binding Proteins (SREBP) signalling;miR-targeted genes in leukocytes - TarBase;miR-targeted genes in lymphocytes - TarBase;miR-targeted genes in muscle cell - TarBase;Vesicle-mediated transport;Membrane Trafficking;Post-translational protein modification;Metabolism of proteins;MHC class II antigen presentation;Immune System;Adaptive Immune System;Class I MHC mediated antigen processing & presentation;Cargo concentration in the ER;Transport to the Golgi and subsequent modification;Asparagine N-linked glycosylation;COPII-mediated vesicle transport;ER to Golgi Anterograde Transport;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
(Consensus)
Recessive Scores
- pRec
- 0.0997
Intolerance Scores
- loftool
- 0.355
- rvis_EVS
- -1.06
- rvis_percentile_EVS
- 7.55
Haploinsufficiency Scores
- pHI
- 0.198
- hipred
- Y
- hipred_score
- 0.516
- ghis
- 0.579
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.814
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Sec24a
- Phenotype
- liver/biliary system phenotype; growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- antigen processing and presentation of peptide antigen via MHC class I;intracellular protein transport;endoplasmic reticulum to Golgi vesicle-mediated transport;antigen processing and presentation of exogenous peptide antigen via MHC class II;cholesterol homeostasis;regulation of low-density lipoprotein particle receptor biosynthetic process;COPII vesicle coating;positive regulation of protein secretion;COPII-coated vesicle cargo loading
- Cellular component
- Golgi membrane;endoplasmic reticulum membrane;cytosol;ER to Golgi transport vesicle membrane;COPII vesicle coat
- Molecular function
- protein binding;zinc ion binding